Nomura Koji, Vilalta Anna, Allendorf David H, Hornik Tamara C, Brown Guy C
Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.
Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom
J Immunol. 2017 Jun 15;198(12):4792-4801. doi: 10.4049/jimmunol.1502532. Epub 2017 May 12.
Activated microglia can phagocytose dying, stressed, or excess neurons and synapses via the phagocytic receptor Mer tyrosine kinase (MerTK). Galectin-3 (Gal-3) can cross-link surface glycoproteins by binding galactose residues that are normally hidden below terminal sialic acid residues. Gal-3 was recently reported to opsonize cells via activating MerTK. We found that LPS-activated BV-2 microglia rapidly released Gal-3, which was blocked by calcineurin inhibitors. Gal-3 bound to MerTK on microglia and to stressed PC12 (neuron-like) cells, and it increased microglial phagocytosis of PC12 cells or primary neurons, which was blocked by inhibition of MerTK. LPS-activated microglia exhibited a sialidase activity that desialylated PC12 cells and could be inhibited by Tamiflu, a neuraminidase (sialidase) inhibitor. Sialidase treatment of PC12 cells enabled Gal-3 to bind and opsonize the live cells for phagocytosis by microglia. LPS-induced microglial phagocytosis of PC12 was prevented by small interfering RNA knockdown of Gal-3 in microglia, lactose inhibition of Gal-3 binding, inhibition of neuraminidase with Tamiflu, or inhibition of MerTK by UNC569. LPS-induced phagocytosis of primary neurons by primary microglia was also blocked by inhibition of MerTK. We conclude that activated microglia release Gal-3 and a neuraminidase that desialylates microglial and PC12 surfaces, enabling Gal-3 binding to PC12 cells and their phagocytosis via MerTK. Thus, Gal-3 acts as an opsonin of desialylated surfaces, and inflammatory loss of neurons or synapses may potentially be blocked by inhibiting neuraminidases, Gal-3, or MerTK.
活化的小胶质细胞可通过吞噬受体Mer酪氨酸激酶(MerTK)吞噬垂死、应激或多余的神经元及突触。半乳糖凝集素-3(Gal-3)可通过结合通常隐藏在末端唾液酸残基之下的半乳糖残基来交联表面糖蛋白。最近有报道称,Gal-3可通过激活MerTK来调理细胞。我们发现,脂多糖(LPS)激活的BV-2小胶质细胞会迅速释放Gal-3,而钙调神经磷酸酶抑制剂可阻断这一过程。Gal-3与小胶质细胞上的MerTK以及应激的PC12(类神经元)细胞结合,并增强小胶质细胞对PC12细胞或原代神经元的吞噬作用,而抑制MerTK可阻断这一作用。LPS激活的小胶质细胞表现出唾液酸酶活性,可使PC12细胞去唾液酸化,而神经氨酸酶(唾液酸酶)抑制剂达菲可抑制该活性。对PC12细胞进行唾液酸酶处理可使Gal-3结合并调理活细胞,以便被小胶质细胞吞噬。小胶质细胞中Gal-3的小干扰RNA敲低、乳糖对Gal-3结合的抑制、达菲对神经氨酸酶的抑制或UNC569对MerTK的抑制,均可阻止LPS诱导的小胶质细胞对PC12的吞噬作用。MerTK的抑制也可阻断原代小胶质细胞对原代神经元的LPS诱导吞噬作用。我们得出结论,活化的小胶质细胞释放Gal-3和一种唾液酸酶,该唾液酸酶可使小胶质细胞和PC12细胞表面去唾液酸化,从而使Gal-3能够结合PC12细胞并通过MerTK介导其吞噬作用。因此,Gal-3作为去唾液酸化表面的调理素,抑制神经氨酸酶、Gal-3或MerTK可能会潜在地阻断神经元或突触的炎症性损失。